Finance

Lists
KIDS:NASDAQ
Orthopediatrics Corp
$22.41
-0.80%
(-0.18) 1D
$22.41
0.00% (0.00)
After hours
Closed: Sep 4, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KIDS...
Open
$22.29
High
$22.56
Low
$21.93
Mkt. cap
585.12M
Avg. vol.
243.72K
Volume
129.51K
52-wk high
$26.74
52-wk low
$14.42
EPS
-$1.68
Beta
0.99
Shares outstanding
26.11M
No. of employees
602
Open
$22.29
High
$22.56
Low
$21.93
Mkt. cap
585.12M
Avg. vol.
243.72K
Volume
129.51K
52-wk high
$26.74
52-wk low
$14.42
EPS
-$1.68
Beta
0.99
Shares outstanding
26.11M
No. of employees
602
News stories
From web sources and news partners
Profile
OrthoPediatrics is an American bio-science company engaged in designing, developing, manufacturing, and distributing orthopedic implants and instruments for pediatric issues. It is based in Warsaw, Indiana. Wikipedia
About Orthopediatrics Corp
CEO-
Employees602
Founded2006
HeadquartersWarsaw, Indiana, United States
SectorMedical device
Websiteorthopediatrics.com
Analyst ratings
Based on 8 analysts giving stock ratings to KIDS in the past 3 months
Strong buy
Buy
7
Hold
1
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for KIDS in the last 3 months.
Highest
Current $22.41
$35.00 (+56.18%)
Average
$27.50 (+22.71%)
Lowest
$22.00 (-1.83%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Zimmerman
BTIG
Buy
Reiterated
$29.00
+29.4%
08/20/2026
Caitlin Roberts
Canaccord Genuity
Buy
Maintained
$28.00
+24.9%
08/12/2026
Richard Newitter
Truist Financial
Hold
Reiterated
$22.00
-1.8%
08/05/2026
Ravi Misra
Truist Financial
Hold
Reiterated
$22.00
-1.8%
08/05/2026
Ben Haynor
Lake Street
Buy
Reiterated
$34.00
+51.7%
08/05/2026
Matthew O'Brien
Piper Sandler
Buy
Reiterated
$25.00
+11.6%
08/05/2026
Rick Wise
Stifel Nicolaus
Buy
Maintained
$24.00
+7.1%
08/05/2026
Michael Matson
Needham
Buy
Reiterated
$35.00
+56.2%
08/05/2026
Mathew Blackman
TD Cowen
Buy
Maintained
$23.00
+2.6%
08/04/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
61.25M
61.60M
59.36M
70.51M
Cost of goods sold
15.98M
16.50M
15.97M
18.14M
Cost of revenue
15.98M
16.50M
15.97M
18.14M
Research and development expenses
2.33M
2.26M
2.23M
2.32M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
47.81M
48.35M
49.49M
54.11M
Operating expense
50.14M
50.61M
51.72M
56.43M
Total operating expenses
66.12M
67.11M
67.70M
74.58M
Operating income
-4.87M
-5.51M
-8.34M
-4.07M
Other non operating income
-648.00K
341.00K
-421.00K
-333.00K
EBT including unusual items
-11.90M
-9.76M
-10.86M
-6.93M
EBT excluding unusual items
-7.34M
-7.10M
-10.86M
-6.93M
Income tax expense
-125.00K
340.00K
-171.00K
234.00K
Effective tax rate
1.05%
-3.48%
1.57%
-3.38%
Other operating expenses
-
-
-
-
Net income
-11.77M
-10.10M
-10.69M
-7.16M
Net profit margin
-19.22%
-16.40%
-18.00%
-10.16%
Earnings per share
-0.24
-0.26
-0.42
-0.26
Interest and investment income
-
-
-
-
Interest expense
-1.82M
-1.93M
-2.10M
-2.53M
Net interest expenses
-1.82M
-1.93M
-2.10M
-2.53M
Depreciation and amortization charges
-
-
-
-
EBITDA
433.00K
96.00K
-2.61M
1.64M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps